Evidence map›Paper›PMID 35177050›Full record

ArticleBMC health services research2022

The risk matrix approach: a helpful tool weighing probability and impact when deciding on preventive and diagnostic interventions.

Stéphanie M P Lemmens, Veronica A Lopes van Balen, Yvonne C M Röselaers, Hubertina C J Scheepers, Marc E A Spaanderman

Open access · goldAbstract read
In one paragraph

Article in BMC health services research, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 19 citations in OpenAlex.

  1. Factors Influencing Physician Adherence to Venous Thromboembolism Risk Assessment Model Recommendations: A Best-Worst Scaling.American journal of cardiovascular drugs : drugs, devices, and other interventions · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Comparing Traditional and Graphical Risk Matrices: A Case Study in Healthcare.Risk analysis : an official publication of the Society for Risk Analysis · 2025
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Stéphanie M P LemmensDepartment of Obstetrics and Gynecology, School for Oncology and Developmental Biology (GROW), Maastricht University, Universiteitssingel 50, Maastricht, 6229 ER, The Netherlands. stephanie.lemmens@maastrichtuniversity.nl.ORCID http://orcid.org/0000-0002-0312-897X
Veronica A Lopes van BalenDepartment of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands.
Yvonne C M RöselaersLimburg Obstetric Consortium, ROS Robuust, Eindhoven, The Netherlands.
Hubertina C J ScheepersDepartment of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands.
Marc E A SpaandermanDepartment of Obstetrics and Gynecology, Maastricht University Medical Center, Maastricht, The Netherlands.
Maastricht University · NLRobuust · NL

Funding

ZonMw 209010006
6 · The paper itself

Abstract

backgroundClinical guidelines are developed to lower risks, mostly viewed upon as probability. However, in daily practice, risk is perceived as the combination of probability and the impact of desired and adverse events. This combination of probability and impact can be visualized in a risk matrix. We evaluated the effect of interventions and diagnostic thresholds on modeled risk, by using the risk matrix approach (RMA) in a clinical guideline development process, and investigated which additional factors affected choices.

methodsTo improve care outcomes, we developed new guidelines in which care professionals had to decide upon novel interventions and diagnostic thresholds. A risk matrix showed the probability and impact of an intervention, together with the corresponding risk category. First, professionals' opinion on required performance characteristics on risk were evaluated by a qualitative online survey. Second, qualitative assessment of possible additional factors affecting final decisions, that followed from group discussion and guideline development were evaluated.

resultsUpfront, professionals opinioned that non-invasive interventions should decrease the general population risk, whereas invasive interventions should decrease the risk in high-risk groups. Nonetheless, when making guidelines, interventions were introduced without reaching the predefined threshold of desired risk reduction. Professionals weighed other aspects besides risk reduction, as financial aspects and practical consequences for daily practice in this guideline-making process.

conclusionProfessionals are willing to change policies at much lower level of anticipated effectiveness than defined upfront. Although objectively presented data structured group discussions, decisions in guideline development are affected by several other factors than risk reduction alone.

Indexed as

ProbabilityHumansDecision-makingImpactProbabilityRisk matrix approach

Identifiers

PMID35177050
PMCPMC8851860
OpenAlexW4212877647

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.